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Abstract. The recent discovery of multilineage 
donor leukocyte microchimerism in allograft recip-
ients up to three decades after organ transplan-
tation implies the migration and survival of donor 
stem cells within the host. It has been postulated 
that in chimeric graft recipients, reciprocal mod-
ulation of immune responsiveness between donor 
and recipient leukocytes may lead, eventually, to 
the induction of mutual immunologic nonreactiv-
ity (tolerance). A prominent donor leukocyte, both 
in human organ transplant recipients and in ani-
mals, has invariably been the bone marrow-
derived dendritic cell (DC). These cells have been 
classically perceived as the most potent antigen-
presenting cells but evidence also exists for their 
tolerogenicity. The liver, despite its comparatively 
heavy leukocyte content, is the whole organ that 
is most capable of inducing tolerance. We have 
observed that DC progenitors propagated from 
normal mouse liver in response to GM-CSF 
express only low levels of major histocompatibility 
complex (MHC) class II antigen and little or no 
cell surface B7 family T cell costimulatory mole-
cules. They fail to activate resting naive allogeneic 
T cells. When injected into normal allogeneic 
recipients, these DC progenitors migrate to 
T -dependent areas of host lymphoid tissue, where 
some at least up regulate cell surface MHC class 
II. These donor-derived cells persist indefinitely, 
recapitulating the behavior pattern of donor leuko-
cytes after the successful transplantation of all 
whole organs, but most dramatically after the 
orthotopic (replacement) engraftment of the liver. 
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A key finding is that in mice, progeny of these 
donor-derived DC progenitors can be propagated 
ex vivo from the bone marrow and other lymphoid 
tissues of nonimmunosuppressed spontaneously 
tolerant liver allograft recipients. 
In humans, donor DC can also be grown from 
the blood of organ allograft recipients whose 
organ-source chimerism is augmented with donor 
bone marrow infusion. DC progenitors cannot, 
however, be propagated from the lymphoid tissue 
of non immunosuppressed cardiac-allografted mice 
that reject their grafts. These findings are con-
gruent with the possibility that bidirectionalleuko-
eyte migration and donor cell chimerism play key 
roles in acquired transplantation tolerance. 
Although the cell interactions are undoubtedly 
complex, a discrete role can be identified for DC 
under well-defined experimental conditions. Bone 
marrow-derived DC progenitors (MHC class II+, 
B7_1'lim, B7-2-) induce alloantigen-specific hypore-
sponsiveness (anergy) in naive T cells in vitro. 
Moreover, costimulatory molecule-deficient DC 
progenitors administered systemically prolong the 
survival of mouse heart or pancreatic islet allo-' 
grafts. How the regulation of donor DC pheno-
type and function relates to the balance between 
the immunogenicity and tolerogenicity of organ 
allografts remains to be determined. 
Introduction 
Ever since the landmark contributions of 
Billingham, Brent and Medawar [I, 2], trans-
plantation has been defined largely in terms of 
a unidirectional immune reaction: host-versus-
defenseless-graft (HVG) following organ trans-
plantation (Fig. lA) and graft-versus-defenseless-
host (GVH) after bone marrow transplantation 
(Fig. IB). In either direction, this one-way 
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Fig. 1. The one- and two-way paradigms of immune interaction following organ or bone marrow transplantation. 
paradigm has failed to elucidate numerous enig-
matic observations including the surprising clin-
ical success of these procedures. However, it now 
appears that the events following both varieties 
of transplantation may be explained by the pre-
viously unsuspected persistence of a trace popu-
lation of immune cells [3-6]. The trace population 
after organ transplantation (microchimerism) was 
discovered in 1992 when donor leukocytes were 
found in the skin, lymph nodes, blood and other 
locations in patients whose kidney or liver allo-
grafts had been functioning for up to 30 years [3, 
7]. The implication was that donor stem cells pre-
sent in the transplanted organ had migrated and 
survived in the recipient [8-10] (Fig. 1 C). 
In the mirror image condition that evolves 
after conventional clinical bone marrow trans-
plantation [3, 10], the trace population consists of 
leukocytes of host origin (Fig. ID), meaning that 
recipient stem cells survive and persist despite 
patient preconditioning with supralethal cytoab-
lation [11, 12]. With either conventional organ 
or bone marrOW transplantation, the quantitative 
disproportion of the coexisting donor and recip-
ient leukocytes is enormous. Nevertheless, there 
is much circumstantial and direct evidence that 
the two cell populations reciprocally modulate 
immune responsiveness, including the induction 
of mutual nonreactivity (the two-way paradigm). 
The implications of this concept at virtually every 
level of transplantation immunology have been 
discussed elsewhere l3-1O, 13]. Here, we will 
consider mechanisms by which the trace popu-
lations of donor cells are sustained and function 
after organ transplantation. 
The distribution of the post-organ transplant 
microchimerism is not homogeneous in host 
recipient tissues [4, 14, 15]. When the blood com-
partment is serially sampled, donor cells wax 
and wane [16, 17] presumably reflecting cyclic 
activity of stem cells after their migration from 
the transplanted organ. This assumption was sup-
ported by Taniguchi et ai. [18] who showed that 
pluripotent stem cells purified from adult mouse 
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livers unfailingly reconstituted all hematolym-
phopoietic lineages in supralethally irradiated 
mouse recipients. In equally convincing experi-
ments, one of our researchers (Noriko Murase) 
demonstrated that supralethally irradiated adult 
rats wcre similarly rescued by syngeneic liver 
transplantation (Fig. 2). Heart transplantation 
also had a less dramatic but significant thera-
peutic effect which resulted in permanent full 
multilineage reconstitution and survival of one 
of six animals and prolongation of survival in 
four others (Fig. 2). In contrast, animals given 3 
ml blood (far more than potentially trapped blood 
in the rinsed organs) died at the same time as 
untreated controls. One-half million fresh bone 
marrow cells were ineffective whereas all ani-
mals given one or five million bone marrow cells 
survived (Fig. 2). Such experiments have made it 
clear that the difference between the chimerism 
(and tolerance) produced by classical bone mar-
row transplantation, and that induced by the 
donor leukocytes that are normal constituents of 
all whole organs, is purely semantic. 
Although the microchimerism is multilin-
eage, dendritic leukocytes (commonly termed 
dendritic cells [DC]) have invariably been 
prominent donor cells in human organ recipi-
ents [3-8 J and in experimental animal models 
[14, 15]. Consequently, we will focus in this 
review on studies of DC and their progenitors in 
mouse liver, heart and bone marrow and of host 
and donor-derived DC in lymphoid tissue of 
recipients of these organs [19-24J. The cell culture 
methods used were modified from the technique 
described by Inaba and Steinman et al. in 1992 for 
the propagation of mouse blood [25 J and bone 
marrow DC [26] in response to GM-CSF. Similar 
studies on rat bone marrow-derived DC have per-
mitted the extensive characterization of these cells 
[27]. We have also succeeded in propagating 
donor-derived DC from the peripheral blood of 
donor bone marrow-augmented human organ 
transplant recipients (see below). 
Choice of Liver and Heart for Study 
Transplantation of the liver and heart lead 
to different immunologic outcomes under 
specifically defined experimental circumstances. 
However. information obtained first in humans 
[3, 4 J but most completely in rat and mouse 
experiments [14, IS, 28] suggests that hepatic 
None. 10.5 (10,10.10,11,12,12) 
Bone marrow 0.5 x 106 • 11.0 (10,11,12) 
1x10· ~========== >100.0 5X10& I >100.0 
Whole blood 3 ml _ 13.0 (12, 13, 13, 13) 
Heartgraft _ 15.0 (1',14 14'1." .lQQ) 
Liver graft >100.0 
Fig. 2. Median survival time (days) of adult Lewis 
(LEW) rats after lethal irradiation and syngeneic 
organ or hone marrow transplantation. The rats were 
lethally irradiated (9.5 Gy) and transplanted with a 
heart or liver organ graft from naive syngeneic 
donors. The end point of this experiment was animal 
survival, which depended on the ability of hematopoi-
etic progenitor cells contained in the organ grafts to 
reconstitute the lethally irradiated recipients. Different 
numbers of unfractionated LEW bone marrow cells 
(0.5, 1.0, or 5.0 x 106) or whole blood (3 ml) were 
also infused to lethally irradiated LEW recipients to 
identify the minimum number of bone marrow cells 
necessary for reconstitution. 
tolerogenicity is merely an extreme example of 
a phenomenon common to all organized tissues 
and organs, with variations in outcome dictated 
by the quantity and lineage profile of leuko-
cytes in the grafts. Consequently, the liver and 
heart with their high and low chimerism poten-
tial, respectively, were chosen for the study of 
progenitor and stem cells. 
The Liver 
In several species including humans, an 
hepatic allograft transplanted after removal of the 
recipient's own liver can induce donor-specific 
tolerance under a temporary umbrella of immuno-
suppression [29-31]. In fact, permanent graft 
acceptance in various animal models occurs with-
out any treatment at all. This is seen unpredictably 
in outbred swine [32-34] but consistently across a 
limited number of rat donor/recipient strain com-
binations [35, 36], and in almost all mouse liver 
recipients, irrespective of the histocompatibility 
barrier [15]. The auto-induction of graft accep-
tance by the liver, whether spontaneous or ini-
tially "assisted" with immunosuppression, extends 
to other tissues or organs transplanted concomi-
tantly or subsequently from the same donor or 
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donor strain [35, 37, 381. We have ascribed this 
hepatic tolerogenicity to hematopoietic "passen-
ger leukocytes" of bone marrow origi n that 
migrate from the liver after transplantation and 
establish residence ubiquitously in the recipient. 
Additionally, the liver is resistant to hyperacute 
(humoral) rejection and shields other donor organs 
from this potential complication. The latter qual-
ity may be explained in part by the prompt change 
in the recipient's complement to predominantly 
donor type after liver replacement [39]. 
The Heart 
An ectopically placed heart allograft (within 
the abdomen) is also potentially tolerogenic but 
weakly so compared to the orthotopically trans-
planted liver. In observations that were inexplic-
able in 1973, Corry et al. [40] described 
spontaneous heart allograft acceptance using a 
mouse strain combination with a major histo-
compatibility complex (MHC) class I disparity 
(BI.AKM--4BlO.BR). Russell eta/. [41] showed 
that mice which permanently accepted kidneys 
from significantly histoincompatible animals 
without treatment were subsequently tolerant to 
donor strain skin. Further, Murase et (I/. [28] have 
demonstrated cardiac tolerogenicity in the rat. 
Choice of Species 
The mouse was the natural choice for the 
progenitor cell studies. Unlike in the rat or 
human. there are several DC lineage-restricted 
markers in the mouse (33D I, non lymphoid DC 
[NLDCJI45. and CDlic [N418]) that can be 
identified using monoclonal antibodies (mAbs) 
[42,431. This added to the attractiveness of 
mouse models for the study of properties of DC 
and their progenitors in lymphoid and nonlym-
phoid organs. Most previous similar mammalian 
investigations have been with this species, from 
which conclusions about tolerance phonome-
nology have been freely extrapolated to higher 
species. The tolerance induced by mouse and 
rat hepatic allografts (to self and other donor 
organs) occurs in spite of retention of don Of-
specific mixed leukocyte reactivity (MLR) and 
cell-mediated Iymphocytotoxicity (CML) (split 
tolerance) [28, 31, 441. a feature also observed 
after the transplantation of various organs in 
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humans [7, 8]. Surprisingly, in the rodent mod-
els, graft acceptance is not associated strongly 
with aT helper-l (Th I )--4Th2 transition of the 
cytokine profile [45] or with the number, phe-
notype, or cytotoxic potential of graft-infiltrat-
ing cells [46]. It is noteworthy that the timc for 
establishment and maintenance of chimerism 
and stable tolerance is shortest in the mouse, 
next in rats and longest in humans. 
A I though nonrej ecting heart trans plan t 
models like those in the mouse have not been 
reported in rats, prolonged drug-free heart graft 
survival can be induced in several strain com-
binations by administering perioperative 
immunosuppression. With a LewiS--4Brown 
Norway rat transplantation model and a short 
course of tacrolimus (formerly FK 506), it was 
possible to determine the relative tolerogenicity 
and the risk of graft-versus-host disease 
(GYHD), associated with four organs (liver, 
heart, kidney and intestine) and four tissue cell 
suspensions (2.5 X 108 cells) prepared from bone 
marrow, spleen, lymph nodes or thymus [281. 
The spectrum of tolerogenicity (without GVHD) 
was liver best--4bone marrow cells next--4heart 
least. The outcome with all of these cell or organ 
transp] antations in rats was strongly correlated 
with the degree of chimerism and also the lin-
eage composition that was produced. The 
engrafted donor leukocytes always included T 
and B lymphocytes. However, the most promi-
nent population when the allografts induced tol-
erance without GYHD consisted of cells of 
myeloid lineage, notably DC [28]. 
The Dendritic Cell: Classical and Changing 
Perceptions 
The ubiquitous presence of donor DC in 
human [3-8] and animal whole organ recipients 
[14, 15] suggested that these cells hold the key to 
tolerance induction. This was conceived to be 
paradoxical at first. Because lymphoid DC are 
the most potent antigen-presenting cells (APC) 
and the only popUlation that can activate 
unprimed T lymphocytes [47], they had been 
widely considered a problem to be overcome, 
not the solution to achieving transplant toler-
ance. Within organs r 48 J or after their migra-
tion to the spleen [49], DC were implicated as 
the mediators of primary stimulation of the 
immune response against donor antigen [50J. 
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The migratory properties of DC are well adapted 
for this role [47, 49-51]. They are widely dis-
persed in lymphoid and nonlymphoid organs and 
in the circulation [47, 52]. Consequently, deple-
tion of DC from allografts in order to reduce 
immunogenicity was a major theme in the trans-
plantation literature throughout most of the first 
two decades after Steinman and Cohn [53] delin-
eated these leukocytes as a separate lineage 
[53-55]. Until 1992, the therapeutic implications 
of the highly immunogenic DC were seen almost 
exclusively in the context of vaccine develop-
ment and potential immunostimulation strategies 
for immunocompromised patients. 
There were, however, hints in the literature 
that DC, the most effective activators of mature T 
cells, could also tolerize developing T cells. Based 
on studies of lymphocytes maturing in chimeric 
mouse thymuses in vitro, Jenkinson et al. [56] 
suggested that lymphoid stem cells entering the 
thymus might acquire tolerance to MHC antigens 
of their own haplotype by interaction with DC, 
the precursors of which also migrate to the thy-
mus. Matzinger and Guerder [57] further showed 
that tolerance was not uniquely induced by thymic 
APC, but that DC from spleen (the most potent 
activators of mature T cells) could also inacti-
vate developing T cells. It was also suggested 
that, as with mature T cells [58], T cell receptor 
(TCR) engagement of self-antigen by develop-
ing thymocytes in the absence of a second signal 
from bone marrow-derived APC could lead to 
clonal anergy [591-
There were further suggestions that DC could 
playa role in shaping peripheral tolerance [60]. 
DC pulsed with high doses of tumor antigen could 
inhibit antitumor immunity [61]. The potential 
of DC to control autoimmune responses by stim-
ulating syngeneic MLR [62] and by implication, 
the induction of suppressor cells [63] had also 
been shown. More recently, DC transfer (from 
pancreatic lymph nodes) has been found to pre-
vent diabetes in non-obese diabetic mice [64l, 
whereas autoantigen (myelin basic protein)-
pulsed thymic DC have induced specific periph-
eral tolerance in experimental allergic 
encephalomyelitis 165]. Shortman and his col-
leagues [66] have recently proposed the exis-
tence of subpopulations of mouse CD8+ lymphoid 
DC with a "veto" function. It has been further 
suggested that these CD8+ DC may contribute 
to Fas-induced apoptosis in peripheral CD4+ 
T cells [67]. 
The Nature of DC 
DC are derived from CD34+ bone marrow 
precursors [68] and may share a common bone 
marrow progenitor with macrophages [69]. They 
were first isolated from mouse lymphoid tissues, 
in particular the spleen [53-55], in the course of 
studies on the function of immune accessory 
cells in culture. The cell surface phenotypic 
markers of lymphoid DC [51, 70] indicate that 
they are not some kind of aberrant macrophage, 
but indeed belong to a unique lineage. As do all 
leukocytes, they express CD45 (leukocyte com-
mon antigen) but unlike macrophages, they 
express low levels of Fc and complement recep-
tors. They do not react with many mAbs directed 
against mononuclear and polymorphonuclear 
phagocytes (e.g., CD13-15, the CDl6 and CD64 
Fc receptors and the mouse macrophage marker 
SER-4). Furthermore, DC do not generally 
express T cell markers (e.g., CD3). Some human 
DC, however, express CD4. DC subsets in 
mouse thymus or bone marrow may express 
CD4 or CDS. DC do not express TCR, B cell 
markers (e.g" membrane immunoglobulin, 
CD 19-22), or CD56/57 (natural killer [NK] 
cells). An important characteristic of (mature) 
lymphoid DC is that they constitutively express 
high levels of MHC class II molecules, whereas 
in macrophages and certain populations of DC 
(often alluded to as "immature") expression of 
MHC class II is inducible in response to various 
cytokines. DC in secondary lymphoid tissues are 
located in T cell areas (interdigitating cells) and in 
splenic marginal zones; in the thymus, they are 
in the medulla. Cells that are indistinguishable 
from lymphoid DC have also been isolated from 
human peripheral blood, There is evidence that 
at least some of these cells in the bloodstream are 
migratory, moving from bone marrow to tissues or 
originating from nonlymphoid tissue and making 
their way to lymphoid organs. 
How do DC Stimulate T Cells? 
Compared to macrophages. mature DC 
within secondary lymphoid tissues take up or 
process antigen only weakly. but have the unique 
capacity to trigger primary T cell responses both 
in vitro and in vivo. They present foreign pep-
tide-MHC complexes to resting T cells and have 
the capacity to deliver an array of costimulatory 
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signals for T cell activation. This may involve 
antigen-independent, intercellular adhesion sys-
tems that operate before antigen recognition via 
the TCR, but which facilitate delivery of as yet 
unidentified DC-derived cytokines. Unlike 
macrophages, DC cannot produce (or produce 
only low levels of) interleukin 1 (IL-l) [70]. There 
is evidence that, like activated macrophages, 
mature DC produce IL-12 [71] that directs nai ve 
T cells towards a Thl pattern of cytokine pro-
duction. Although both macrophages and DC 
express OM-CSF receptors (OM-CSFR), only 
macrophages express M-CSFR [72]. Intimate 
contact between the DC and T cells may facilitate 
the delivery of activation signals via a variety of 
defined pathways, including B7/CD2S, leuko-
cyte function antigen-3 (LFA-3) [CD5S]lCD2 
and intercellular adhesion moleculc-l (ICAM-I) 
[CD54]/LF A-I [73-76], or via DC-restricted 
molecules, such as N41S (CD II c) in the mouse. 
Other potential T cell signaling molecules 
expressed by DC include CD5 [77, 7S], MHC 
class I molecules [79, SO], the various isofomls of 
CD45 [SI1, heat stable antigen (HSA) and CD40. 
DC Heterogeneity 
DC subsets located in distinct compart-
ments within the blood or the same (lymphoid) 
tissue (e.g., the mouse spleen or thymus) can 
exhibit phenotypic heterogeneity with respect 
to the expression of DC-restricted markers, 
MHC class II and T cell costimulatory mole-
cules [51, S2]. This may reflect possible func-
tional differences. Indeed evidence has 
emerged from several laboratories to support 
functional heterogeneity of DC and the presence 
both of precursor and mature DC within blood, 
lymphoid and nonlymphoid tissues [83-89]. 
DC in Nonlymphoid Organs 
Members of the DC lineage are believed to 
be distributed ubiquitously. Until recently, little 
was known about the properties of potential 
migratory DC resident in nonlymphoid organs, 
i.e., the liver, heart and kidney, that are commonly 
transplanted. Although the migration of DC from 
liver [15] or cardiac allografts [49] to T-dependent 
areas of recipient spleens has been studied in 
mice, the functional properties of these cells, or of 
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the precursors from which they are derived have 
only recently been described [19, 21, 88, 90]. The 
best characterized DC isolated from nonlymphoid 
tissues are the MHC class II+ epidermal 
Langerhans cells (LC) [91]. When freshly iso-
lated, these cells have a phenotype distinct from 
"mature" lymphoid DC and can process exoge-
nous antigens. They possess Fe receptors, lyso-
somal enzymes, and some macrophage markers 
and exhibit avid phagocytic activity. However, 
they express low levels of critical cell surface 
costimulatory molecules (B7- I and B7-2) and are 
poor initiators of naive T cell responses. Such 
cells may have tolerizing potential. When cul-
tured in OM-CSF, however, LC can mature into 
cells resembling lymphoid DC [92-95]-their 
phagocytic and antigen-processing activities are 
lost. They upregulate cell surface MHC class II 
antigen expression and become mature, potent 
APC with costimulatory activity for T cells [93]. 
This transformation is accompanied by pheno-
typic remodeling of the cell surface and changes 
in other properties [94-96]. Thus, freshly isolated 
mouse LC express CD32 (FcyRII) receptors and 
the "macrophage" marker F4/S0, but not IL-2 
receptors (IL-2R) (CD25); cultured LC, on the 
other hand, attain a low buoyant density and have 
the reciprocal cell surface phenotype. CR3 
(CDllb/CDI8) and the nonlymphoid DC marker 
NLDC 145 are, however, retained during matu-
ration. Recent evidence indicates that the expres-
sion of at least two (T cell) costimulatory 
molecules (B7-1 [CD80] and B7-2 [CD86]) on 
mouse LC is upregulated with enhanced 
immunostimulatory function [87,97]. 
Recently, it has been shown that, like fresh 
LC, DC isolated from mouse kidneys and 
hearts cannot stimulate allogeneic T cells 
unless cultured overnight [8S]. These DC from 
nonlymphoid organs thus resemble immature 
rather than mature DC. The immunostimula-
tory function reported for all DC isolated from 
non lymphoid organs may therefore be a con-
sequence of in vitro maturation in culture. The 
hypothetical stages of DC maturation can be 
outlined as shown in Table 1. 
DC Progenitors as Candidate Tolerance-
Inducing Cells 
The possibility has been raised that resident, 
unperturbed, costimulatory molecule-deficient 
-------------------- , 
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Table I. Hypothetical stages of dendritic cell (DC) maturation (modified after Austyn; [51]) 
Stage Location Phenotype Function 
DC bone marrow and blood: MHC cl IT-/dim Give rise to DC 
Progenitors thymus; nonlyrnphoid and 
secondary lymphoid tissue 
"Immature" Skin epidermis (LC); FcW: B7 MHC cI I+/W Antigen uptake and 
DC interstitial DC in other processing; expression of 
nonlymphoid organs antigen peptide-MHC 
complexes; poor 
allostimulatory capacity 
Migratory Blood and afferent lymph DC Heterogeneous (transitional) Migration to 2° lymphoid 
DC and non lymphoid tissues 
Mature DC Lymphoid tissue FcR B7': MHC cl J+lIlh,gh; Presentation of antigenic 
DC-restricted markcrsa peptide-MHC complexes 
(heterogeneous) and costimulatory signals 
to T cells" 
--- - -----
aCan also be expressed on immature cells; 
hln the thymus, self-peptide-MHC complexes arc presented to developing T cells and induce tolerance; 
LC = Langcrhans cells 
------------ --,----
DC within nonlymphoid tissue may have toler-
izing potential. Experiments addressing this issue, 
however, have been compromised by a lack of 
solid organ-derived cells (DC) to test with the T 
cells of the recipients, Development of the means 
to propagate DC progenitors from mouse liver in 
response to GM-CSF [19] provides a basis upon 
which to test the hypothesis, both in vitro and in 
vivo, Additionally, the availability of growth fac-
tors (GM-CSF [25, 26], tumor necrosis factor-a 
(TNF-a) [68,98,99], IL-4 [99], stem cell factor 
r 1 00] and others) that induce proliferation and 
intluence maturation of DC progenitors offers a 
means of investigating the regulation of the liver 
DC phenotype and function in relation to hepatic 
tolerogenicity/immunogenicity. 
Difficulties Encountered in Studying Liver 
and Other Nonlymphoid Organ DC 
Although presumptive interstitial DC have 
been demonstrated previously by immunohisto-
chemical methods in the portal tri ads of normal 
rodcnt [90, 101-103] or human [104] liver and in 
the heart [10 1-103], little has been documented 
about their function, especially in relation to the 
activation of naive T cells. Our studies [90] have 
shown that a popUlation of "mature" DC similar 
in function to the prototypic spleen DC [53-551 
can be isolated from the nonparenchymal cell 
(NPC) population in normal mouse liver by 
overnight culture and differential centrifugation. 
These cells exhibit potent allostimulatory activ-
ity for unprimed T cells_ However, isolation 
methods for these liver DC include steps that 
may induce phenotypic and functional change. In 
addition, these cells represent only a small per-
centage of the leukocyte populations and of other 
potential APC resident in normal mouse liver-
Propagation of Liver DC Progenitors in 
Response to GM-CSF 
Following reports by Steinman's group that 
large numbers of DC progenitors could be 
induced to proliferate from normal mouse blood 
or bone marrow when cultured with GM-CSF 
[25, 26], we determined whether, using a similar 
approach, liver-derived DC progenitors could be 
propagated in liquid cultures. After four days of 
culture of liver NPC, during which non adherent 
granulocytes were removed by gentle washes, 
growth of cell "clusters" attached to a layer of 
adherent cells was evident [19]; many den-
dritic-shaped cells appeared to have been released 
from the clusters and exhibited "sheet-like" cyto-
plasmic processes. With more prolonged culture 
in GM-CSF, these cells detached from the aggre-
gates and many mononuclear cells, with a typical 
Thomson et al. 
dendritic shape, were seen either loosely attached 
or floating in the culture medium. However, in 
the absence of GM-CSF, no cellular proliferation 
was seen. Adherent macrophages and fibroblasts 
also expanded in the liver cell cultures in the pres-
ence ofGM-CSF, but remained firmly attached to 
the plastic surface. The floating or loosely adher-
ent, putative liver DC were harvested by gentle 
aspiration for further phenotypic or functional 
analyses. By day 7 of culture, approximately 2.5 
x 106 of these cells per normal mouse liver could 
be harvested from the cultures. 
The surface immunophenotype of cells 
released from proliferating liver cell aggregates 
was determined by flow cytometric analysis after 
6- I 0 days or further periods of culture in 
GM-CSF. Staining for cells of lymphoid lin-
eage, including NK cells, was absent. The float-
ing cells in the liver-derived cultures strongly 
expressed surface antigens that are known to be 
associated with mouse DC (Fig. 3) in addition to 
other cells. These included CD45 (leukocyte 
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Fig. 3. Merged FACScan® immunophenotypic pro-
files of GM-CSF-stimulated mouse liver-derived DC 
progenitors released from cell aggregates in liquid 
culture (day 10) and examined using rat, hamster or 
mouse mAbs. [Reproduced from the J Exp Med. 
1994; I 79: I 828, by copyright permission of the 
Rockefeller University Press]. 
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common antigen), HSA, ICAM-I (C054), CDllb 
(MAC-I), and CD44 (nonpolymeric determinant 
of phagocytic glycoprotein-I [Pgp.l D. In addi-
tion, staining of weak to moderate intensity was 
observed for the mouse DC-restricted markers 
NLDCI45 (interdigitating cells), 33Dl and N4IS, 
and for F4/80 and FcyRIl (CD32). The intensity 
of expression of these markers on OM -CSF-stim-
ulated spleen-derived cells was similar, except 
that 33D 1 and NLDC 145 were slightly more 
and less intense, respectively, compared to the 
liver-derived cells. 
In contrast to the observation of Inaba et 
ai. [25] however, concerning the progeny of cir-
culating DC precursors, and to our own pub-
lished findings on OM-CSF-stimulated 
spleen-derived DC [105], liver-derived cells that 
were similarly propagated expressed only a low 
level of surface MHC class II (I-El) antigen. 
They were therefore classified as DC progeni-
tors. The intensity of MHC class II expression on 
the Ii ver DC progenitors could not be increased 
by using higher concentrations of GM-CSF 
(0.4-0.S ng/ml) and/or by extending the period of 
culture for up to four weeks. Similar recent 
observations of immature (MHC class II-) iso-
lated from the respiratory tract of neonatal rats 
have shown that these cells are refractory to the 
stimulatory effects of OM-CSF [106]. The low 
intensity of MHC class II expression on the liver 
DC progenitors suggested that these proliferating 
cells, though possessing several surface markers 
indicative of developing DC, were still at a 
phenotypically immature stage of differentia-
tion. Further efforts to induce MHC class II anti-
gen expression included combination of 
GM-CSF with TNF-a (500 Dlml) andlor inter-
feron-y (IFN-y) (1000 Dlml) for up to five days, 
or culture on a "feeder layer" of irradiated, syn-
geneic spleen cells. None of these treatments 
significantly affected the expression of cell sur-
face MHC class II on the putative liver DC pro-
genitors. An important stimulatory factor or 
cofactor was absent. 
Allostimulatory Activity of GM-CSF-
Propagated Liver DC Progenitors 
In view of the comparatively low cell sur-
face expression of MHC class II on the 
OM-CSF-stimulated liver DC progenitors, it 
was of interest to determine their allostimulatory 
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activity. Our prediction was that they would 
show little or none. When compared to 
GM-CSF-stimulated spleen cells propagated 
and harvested using the same techniques, the 
cultured liver-derived DC progenitors failed to 
induce naive, allogeneic T cell proliferation as 
predicted. GM-CSF-stimulated spleen-derived 
DC, however, which expressed much higher 
levels of surface MHC class II antigen, were 
more efficient inducers of quiescent, allogeneic 
T cells than freshly isolated spleen cells. 
Furthermore, failure of the GM-CSF-stimulated, 
putative liver DC progenitors to induce MLR 
contrasted with the potent allostimulatory activ-
ity of an overnight-cultured, nonadherent, low 
density mature DC-enriched population that was 
prepared from freshly isolated normal mouse 
liver NPC, using conventional methods [82]. 
Next, we tested an extracellular matrix protein 
(EMP), type-I collagen, that is spatially asso-
ciated with liver DC in situ and adherence to 
which is known to alter both the phenotypic 
characteristics and function of mononuclear 
leukocytes [107-109]. 
Upregulation of DC-Restricted Markers, 
MHC Class II and Allostimulatory Activity 
by Exposure of GM-CSF -Stimulated, Liver-
Derived DC Progenitors to Type-! Collagen 
Seven-day, GM-CSF-stimulated liver-derived 
DC progenitors expressing low levels of MHC 
class II were transferred to culture plates precoated 
with rat tail type-l collagen and maintained for 
three additional days in the presence ofGM-CSF. 
Cell proliferation was observed on the colla-
gen-coated plates, accompanied by a relative 
increase in nonadherent cells as compared to con-
trol cultures (collagen-free). Immllnophenotypic 
analysis of the nonadherent cells showed marked 
upregulation in the intensity of expression of 
the DC markers NLDCI45, 33Dl and N418. 
Such upregulation of DC-restricted markers 
had been shown previously by Inaba et al. in 
GM-CSF-stimlllated mouse bone marrow cell cul-
tures [261. Of particular interest, however, was 
the marked upregulation of cell surface MHC class 
II expression observed on liver DC progenitors 
(MHC class IIdim or class II-) propagated for an 
additional three days with GM-CSF on type-l col-
lagen-coated plates, as compared to similar cells 
maintained in collagen-free cultures (Fig. 4) [19]. 
Following exposure to type-l collagen, the 
liver DC progenitors became potent inducers 
of MLR, in marked contrast to la-depleted 
cells maintained in GM-CSF alone, which 
failed to elicit T cell proliferation. These MHC 
class IIbrigh" liver-derived DC also proved more 
potent MLR stimulators than freshly isolated 
spleen cells, although not as potent as 
GM-CSF-stimlliated spleen-derived DC. This 
added further weight to our contention that the 
liver DC progenitors had undergone maturation 
following three-day culture in the presence of 
type-I collagen and GM-CSF. 
In Vivo Migration (Homing) ofUver-Derived 
DC Progenitors in Allogeneic Recipients 
A specialized property of DC is their capac-
ity to "'home" to T-dependent areas of peripheral 
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Fig. 4. Flow cytometric analysis of the expression of 
MHC class II (I-E') on GM-CSF-stimulated mouse 
liver DC progenitors before and after exposure to 
type-l collagen. All Ia+ cells were depleted from 7-d 
cultures of liver-derived cells released from aggre-
gates in GM-CSF-supplemented medium by treat-
ment with anti-Ia (I-Ek) mAb and complement; the 
cells were then exposed for a further 3 d to type-l 
collagen 1) in the continuous presence of GM -CSF 
(0.4 ng/m\) or 2) maintained without collagen. An 
isotype-matched irrelevant antibody was used as a 
negative control. lReproduced from the J Exp Med, 
1994; 179: 1830, by copyright permission of the 
Rockefeller University Press]. 
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lymphoid tissues [49, 110, III]. To assess the 
homing ability of the liver DC progenitors propa-
gated in culture, lO-day GM-CSF-stimulated cells 
( I or 2.5 X 105 low I-P expression or Ia- following 
complement-mediated lysis, respectively) were 
injected s.c. into one hind footpad or i.v. into allo-
geneic B 10 (I-E-) recipients. For comparative 
analysis, strongly class II+ GM-CSF-stimulated 
spleen DC (10-day cultures) were injected into 
separate animals. One to five days later, the ani-
mals were sacrificed, and cryostat sections of the 
draining lymph nodes (where appropriate) and 
spleens were stained with donor-specific mAb 
(anti-I-Ek). Liver-derived DC progenitors, prop-
agated in GM-CSF-supplemented cultures, homed 
after injection almost exclusively to the T cell 
areas ofrecipients' spleens. 
The allogeneic donor cells were found con-
sistently in close proximity to arterioles [19,21]. 
Similar observations were also made in the 
draining lymph node of footpad-injected mice. 
Moderate to intense I-P expression was detected 
on the liver-derived cells, many of which also 
exhibited distinct dendritic morphology. At day 
5 after injection, liver-derived DC in the recipi-
ents' spleens were more abundant than strong 
class IF spleen-derived DC [21], which also 
homed after injection to T cell areas of recipi-
ents' spleens and lymph nodes. Similar obser-
vations were made whether ladim or la-depleted 
cells were injected. In the latter instance, how-
ever, the incidence of positive cells was reduced. 
These observations suggest that after injection, 
at least some of the liver DC progenitors upreg-
ulate their MHC class II surface antigen. As 
shown previously for other nonlymphoid organ 
DC [49, 111], immature liver DC propagated in 
culture also exhibit a key functional property of 
this cell lineage-the capacity to home to 
T-dependent areas of secondary lymphoid tis-
sue and therein to strongly express MHC class II 
cell surface antigen. Following liver transplan-
tation, the function of these donor-derived cells 
could influence the balance between the 
immunogenicity and tolerogenicity of the graft. 
Persistence of Liver-Derived DC Progenitors 
and Their Progeny in Allogeneic Hosts 
The foregoing donor MHC class 1I+ (I-P+) 
cells could still be detected in T cell areas, in 
the same close proximity to arterioles, at least 
631 
two months after the injection of liver DC pro-
genitors [21]. Rarely, mitotic figures were 
observed [21]. These findings are congruent 
with earlier observations on the persistence of 
cells with donor phenotype and distinct DC mor-
phology within lymphoid and nonlymphoid 
organs of orthotopic liver allograft recipients 
many months after transplantation [3,4, 15, 28, 
112]. In mice, two-color immunohistochemical 
analysis has confirmed the identity of these cells 
as donor liver-derived DC [15]. 
Growth of Donor-Derived DC Progeny from 
Lymphoid Tissue of Liver-Allografted Mice 
Bone marrow or spleen cells were isolated 
from unmodified mouse orthotopic liver trans-
plant (OL Tx) recipients (male B 10; [H-2 b, 
I-N]-+female C3H; [H-2k;I-PD 14 days after 
transplantation. The cells were cultured for 10 
days in GM-CSF employing the techniques 
described above to enrich for DC lineage cells. 
U sing now cytometric and immunocytochemical 
analysis for donor MHC class 1+ and Il+ cells, 
respectively, a minor population of cells of donor 
phenotype (in addition to recipient cells) was 
found to propagate in culture. Polymerase chain 
reaction (PCR) analysis, using probes specific 
for the sex-determining region of male donor Y 
chromosome, or donor MHC class II (in the 
B 1 O.BR ---+ B I 0 strain combination) revealed 
growth of cells of donor origin in bone marrow 
(especially) (Fig. 5) and spleen cell cultures 
propagated from female recipients of male livers 
l22-24]. No signal for donor-derived cells could 
be detected in IO-day GM-CSF-stimulatcd cul-
tures of thymocytes from liver allograft recipi-
ents [23]. This suggested that the thymus may 
not be an appropriate microenvironmental niche 
for donor-derived DC progenitors, in spite of 
the identification there of mature DC [14]. 
We next sought direct evidence that the 
donor-derived cells propagated from the bone 
marrow of liver allograft recipients were of DC 
lineage. Sorting of donor-positive cells was con-
sidered, but the anticipated yield of cells was 
calculated to be too low for subsequent func-
tional analysis. Instead, I O-day GM-CSF-stim-
ulated bone marrow-derived cells were 
harvested, NLDC 145+ cells were sorted (at least 
90% purity by morphologic and FACScan@ 
analysis) and then investigated for the presence 
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Fig. 5. Detection of the donor Y chromosome in 
freshly isolated (day 0) and IO-d GM-CSF-stimu-
lated bone marrow cells from female (C3H) recipi-
ents of male (B 10) livers or hearts. The mice were 
sacrificed 14 d or 8 d, respectively, after transplan-
tation. In this strain combination, liver allografts 
are accepted spontaneously, whereas heart grafts 
are rejected with a median survival time of 8 d. 
Growth of donor-derived cells is evident in the DC 
cultures propagated from the bone marrow of I i vcr 
allograft recipients, whereas there is little evidence 
of survival of male cells in the cultures from heart 
graft recipients. [Reproduced from the J Exp Med, 
1995;182:384, by copyright permission of the 
Rockefeller University Press]. 
of donor Y chromosome. As shown in Figure 6, 
PCR analyses demonstrated convincingly that 
the highly purified DC population comprised 
approximately 1-10% Y chromosome-positive 
(donor-derived) cells in addition to recipient strain 
DC [23]. Further evidence for the presence of 
donor-derived DC was obtained by testing the 
allostimulatory activity of sorted, NLDC 145+ 
GM-CSF + IL-4-stimulated bone marrow-derived 
cells in primary MLR. Here, IL-4 was used to 
promote ex vivo DC maturation, since this was 
necessary for the detection of allostimulatory 
activity. The purified NLDC 145+ population 
propagated from C3H recipients of B 10 allo-
grafts strongly stimulated B 10 (donor strain) 
responders, but also stimulated a response in 
recipient strain T cells [23]. The extent of stim-
ulation (p < 0.01 compared to negatively sorted 
cells or syngeneic DC) was similar to that 
achieved with "artificial mixtures" containing 
Fig. 6. Demonstration that donor-derived cells in 
IO-d GM-CSF-stimulated bone marrow cell cultures 
from Iiver-allografted mice are DC. PCR analysis of 
pre- and post-sorted cells, showing the presence of 
donor-deri ved Y chromosome in the NLDC 145+ 
(DC) fraction. [Reproduced from the J Exp Med, 
1995;182:383, by copyright permission of the 
Rockefeller University Press]. 
1% GM-CSF + IL-4-stimulated donor strain 
(B 10) DC. The in vivo functional role of donor-
derived DC progenitors in the lymphoid tissue 
of spontaneously tolerant liver allograft recipi-
ents remains to be determined. The capacity, 
however, of bone marrow-derived DC progeni-
tors to induce alloantigen-specific anergy in T 
cells in vitro has recently been demonstrated 
(see below). An additional consideration is that 
presentation of allopeptides (derived from donor 
APC) by recipient DC (the indirect pathway of 
antigen presentation) [113] may be important 
for the induction of unresponsiveness. 
Failure to Propagate Donor-Derived Cells 
from Bone Marrow of Mice Rejecting Heart 
Allografts 
In contrast to liver allograft recipients, non-
immunosuppressed C3H mice reject heart allo-
grafts from the same donor strain (B I 0) within 
ten days [15]. PCR analysis for donor Y chro-
mosome was performed on 1O-day GM-CSF-
stimulated cultures of bone marrow cells 
harvested from heterotopic cardiac allograft 
recipients eight days after transplant. In con-
trast to the results obtained from liver graft 
recipients, no evidence was obtained for the 
propagation of donor-derived cells from the 
bone marrow of animals rejecting their cardiac 
grafts (Fig. 5) despite evidence of small num-
bers of chimeric cells in freshly isolated bone 
marrow [23]. Thus heart-derived cells, in con-
trast to those detected in fresh bone marrow of 
liver allograft recipients, appear not to contain 
sufficient numbers of GM-CSF-responsive pro-
genitors for growth of donor-derived cells (as 
Thomson et al. 
opposed to amplification in the case of liver 
grafts) after 10 days of culture. 
Propagation of Donor-Derived DC from the 
Blood of Bone Marrow-Augmented Human 
Liver Allograft Recipients 
Donor-derived DC progenitors have also 
been propagatcd in culture from peripheral blood 
mononuclear cells (PBMC) of donor bone mar-
row-augmented human liver transplant recipi-
ents. The patients studied have been involved in 
a trial in which the infusion of unmodified donor 
vertebral body bone marrow at the time of organ 
transplant has been performed to augment donor 
cell microchimerism [114]. Representative data 
obtained for one bone marrow-augmented liver 
transplant patient are shown in Figure 7. PBMC 
werc obtaincd 590 days post-transplant. DC werc 
propagated in GM-CSF + IL-4-enriched medium 
using a modification of a method described pre-
viously 1115 J. On day 15 of culture, nonadherent 
cells of dendritic morphology were harvested 
and subjected to double immunofluorescence 
staining using a cocktail of phycoerythrin (PE)-
labeled lineage-specific (CD3, CDI4, CD22 and 
CD56) and fluorescein isothiocyanate-labeled 
anti-HLA-DR antibodies. Subsequent to stain-
ing, the lineage- and HLA_DRb'ight cells were 
sorted and their purity confirmed by reanalysis. 
Within the sorted population, the presence of 
donor DNA (HLA-DR4) was determined by PCR 
amplication followed by Southern blotting (Fig. 
7D, arrow). The knowledge obtained from stud-
ies of these donor-derived cells may provide new 
insight into the mechanistic basis of tolerance 
induction. [t may also aid the development of 
strategies for the use of cellular immunotherapy 
to enhance allograft acceptance. 
Bone Marrow-Derived DC Progenitors Induce 
Alloantigen-Specific Unresponsiveness 
(Anergy) in T Cells In Vitro 
DC progenitors were propagated from B 10 
mouse bone marrow in response to GM-CSF. The 
methods used were similar to those employed to 
propagate DC progenitors from normal mouse 
liver. Cells expressing DC lineage markers 
(NLDC l45+, 3301 +, N418+) harvested from 
8-1 O-day GM-CSF-stimulated bone marrow cell 
P 
E 
A. Scalier Profile-
Pre-sort 
FSC 
C. II LA-DR versus Lineage 
PGE:5..14% 
633 
~ R. Autonuoresc:ence 
D. HL\-DR versus Lincage 
mre-~EFrt L6- --~-
I P 
N 
E 
A 
G 
E 
P 
E 
'""-
KD_D::D~/D:_ ... --tIt"-
10' 10' '0' 
HLA-DRFITC 
, .. 
'0' 
Fig. 7. Detection of donor-derived DC in GM-CSF 
+ IL-4-stimulated cultures propagated from the blood 
of a donor bone marrow-augmented liver transplant 
patient. PBMC obtained from the liver recipient 590 
days post-transplantation were cultured using a mod-
ification of a method described previously r II 5]. On 
day 15 of culture, nonadherent cells of dendritic mor-
phology were harvested and subjected to double 
immunofluorescent staining using a cocktail of PE-
labe led lineage-specific (CD3, CD 14. CD22 and 
CD56) and FITC-Iabeled anti-HLA-DR antibodies. 
Subsequent to staining, the lineage- and HLA_DRbright 
cells were sorted and their purity confirmed by 
reanalysis. Within the sorted population, the pres-
ence of donor DNA (HLA-DR4) was determined by 
PCR amplication followed by Southern blotting (D, 
arrow). A) Scatter profile of cells prior to sorting. 
Large granular cells within the gated region (Rl) 
were selected for sorting. B) Analysis of autofluo-
rescence of unstained cells within the gated region 
(A; R I) used to set the quadrants to view positive 
Fluorescence. C) The purity of the sorted cells (lin-
eage HLA_DRhright) was increased hy creating a 
decreased sorting region (R2). 
cultures were CD45+, HSA+, CD54+ and CD44+. 
They were MHC class n+, B7-\ Jim (CDROeli"') but 
87-2- ECaUS~F (costimulatory molecule deficient) 
(Fig. 8). Supplementation of cultures with IL-4 
in addition to GM-CSF, however, resulted in 
marked upregulation of surface MHC class II and 
B7-2 expression [116] (Fig. 8). These latter cells 
exhibited potent allostimulatory activity in pri-
mary mixed leukocyte cultures. In contrast, the 
cells stimulated with GM-CSF alone were very 
weak stimulators. They induced alloantigen-spe-
cific hyporesponsiveness in allogeneic T cells 
(C3H) detected upon restimulation in secondary 
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Fig, 8. FACScan® profiles of DC progenitors (costim-
ulatory molecule-deficient) and "mature" mouse bone 
marrow-derived DC. Above, expression of MHC class 
II (I-N), B7-1 and B7-2 on 8-d GM-CSF-stimulated 
DC progenitors ("immature" DC); below. 8-d GM-CSF 
+ IL-4-stimulated B I 0 bone marrow-deri ved "mature" 
DC. Whereas the mature DC were potent stimulators of 
allogeneic T cells, the DC progenitors induced alloanti-
gen-specific T cell hyporesponsiveness (anergy). For 
further details, see Lu et at. [116]. [Reproduced from 
Transplantation 1995, in press, by permission of 
Williams and Wilkins, Baltimore, MOl 
MLR [116]. This was associated with blockade 
of IL-2 production. Reactivity to third party 
stimulators was intact. The hyporesponsiveness 
induced by the GM-CSF-stimulated, costimu-
1atory molecule-deficient DC progenitors was 
prevented by incorporation of anti-CD28 mAb 
in the primary MLR. It was reversed by the 
addition of IL-2 to restimulated T cells [116]. 
These findings show that MHC class 11+ B7-2-
DC progenitors can induce alloantigen-spc-
cific hyporesponsiveness in T cells in vitro. 
Under the appropriate conditions, donor-
derived, costimulatory molecule-deficient DC 
progenitors could contribute to the induction of 
donor-specific unresponsiveness to graft 
alloantigens in vivo. 
DC Progenitors Prolong Organ Allograft 
Survival 
We have obtained evidence that GM-CSF-
stimulated DC progenitors (B7-2-) capable of 
inducing T cell hyporesponsiveness in vitro can 
also prolong heart allograft survival. In the 
B IO--...C3H model, 2 x 106 B7-2- B 1 0 DC pro-
genitors were given i.v. seven days before trans-
plantation. These cells significantly prolonged 
heart graft survival compared to syngeneic 
(C3H) or third party (BALB/c) cells [117] 
(Table II). In contrast and as expected, mature 
(B7-2+) DC reduced mean graft survival time. 
The nonspecific effect of third party DC pro-
genitors (although significantly less than that of 
allogeneic cells) is also of interest, although its 
mechanistic basis is not at present understood. 
DC Progenitors Prolong Pancreatic Islet 
Allograft Survival 
We have also tested the in vivo relevance 
of cultured DC progenitors in a pancreatic islet 
Table II. Influence of one injection of donor-specific GM-CSF-stimulated DC progenitors (B7-2') on B 10 
cardiac allograft survival in C3H mice 
Group Cells injected (d-7) Graft survival times Mean± I SD MST n (days) 
A None (media control) 8 8(x3), 12 ,13(x2), 9,10 10.1 ± 2.2 9.5 
B Fresh B 10 bone marrow cells 4 12(x4) 12 12 
Cultured cells 
C B 10 (B7-2+) (allogeneic) 5 4(x2), 7, 8, 14 7.4 ± 4.1 7' 
D B 10 (B7-2-) (allogeneic) 8 19(x3), 22(x2), 23, 27, 35 23.3 ± 5.5 22,b 
E C3H (B7-2-) (syngeneic) 4 12(x2), 13(x2) 12.5 ± 0.6 12.5 
F BALB/c (B7-2-) (third party) 6 12.I7(x2), 16, 19,20 16.8 ± 2.8 17 
Cells (2 x 106 i.v.) were injected 7 d before heterotopic (B I 0-'C3H) heart transplantation. n = number of mice. 
MST = median survival time. MST compared by the Kruskal-Wallis test. Pair-wise comparison by the Wilcoxon 
Sum Rank Test. " p < 0.003 compared with groups C and E; b. p < 0.01 compared to group F; ',p < 0.01 compared 
to groups D and F. 
Thomson c( al. 
allograft model. Two days after rendering groups 
of BIO (H-2h; I-A+) mice diabetic with strepto-
zotocin, and seven days before transplantation 
with 700 islet equivalents (99'1<.' pure) under the 
left renal capsule, the animals received i.v. either 
culture medium, 2 x 10(, allogeneic (B 10.BR; 
H-2k I-E+) or syngeneic, 10-day cultured 
GM-CSF-stimulated liver DC progenitors or 
IO-day cultured GM-CSF-stimulated mature 
spleen DC. 8100d glucose and body weights 
were recorded daily. The graft survival times 
(Fig. 9) show that GM-CSF-stimulated liver DC 
progenitors prolong allograft survival [118]. 
Conclusions 
Model systems have been established 
which allow the evaluation, both in vitro and in 
vivo, of factors that regulate the growth, phe-
notype and function of DC. These cells have 
the capacity to direct the immune response, to 
determine its strength and to affect the balance 
between tolerance and immunity. However, it 
should be emphasized that the DC is only one 
of the hematolymphopoietic lineages repre-
sented in the microchimerism of the success-
fully engrafted whole organ recipient. The 
chimerism obviously is dependent on pluripo-
tent stem cells for maintenance. The reduc-
tionist approach we have reviewed herc could, 
therefore, distance us from the context we are 
seeking to understand. That context is one of 
a complex immune reaction that probably can 
neither be generated nor efficiently sustained 
by any single lineage [119]. Nevertheless, 
understanding the molecular regulation both of 
MHC class II gene product and T cell costim-
ulatory molecule expression by the donor bone 
marrow-derived APC, and how this relates to 
T cell activation or unresponsiveness 
(ancrgy/clonal deletion) is a central issue in 
transplantation immunology. Such knowledge 
may be key to clarifying the role of donor-
derived (chimeric) DC in host responses to 
liver and other whole organ transplants and to 
further understanding the inherent tolero-
genicity that is a feature of all organs but most 
highly represented by the Ii veL MHC gene 
product and costimulatory molecule expres-
sion (87-1 and B7-2 are thought to be the most 
important) on donor-derived DC may be cru-
cial for effective antigen presentation and Th 1 
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Fig. 9. Influence of cultured DC progenitors on 
B IO.BR (H-2k) pancreatic islet allograft survival in 
B 10 mice (H-2 b). Cultured liver (L) or spleen (S) 
derived cells (2 x 106 ) were injected i. v. 2 d after the 
recipient animals were made diabetic with i.p. injec-
tion of streptozotocin. The animals were maintained 
on insulin (1-2 JU/day) until pancreatic islet trans-
plantation. Pancreatic islets (700IEq/mouse) were 
placed beneath the left renal capsule seven days after 
(he injection of cultured GM-CSF-stimulated liver 
DC progenitors or spleen-derived DC ("mature" DC). 
For further details, see Rastellini et al. [118]. 
[Reproduced from Transplantation 1995, in press, by 
permission of William and Wilkins, Baltimore, MD]. 
cell activation following liver transplantation. 
Conversely, their absence on donor-derived 
APC expressing even low levels of MHC gene 
products may favor tolerance induction by one 
or more mechanisms. Indeed, we have shown 
that, in vitro, bone marrow-deri ved DC pro-
genitors (MHC class IF B7-1 diIll, 87-2-) can 
induce alloantigen-specific hyporesponsive-
ness (anergy) in naive T cells. Further infor-
mation is needed on the in vivo relevance of 
donor-derived DC progenitors, based on the 
finding that these cells can be propagated from 
the lymphoid tissue of spontaneously tolerant 
mouse liver graft recipients and from the blood 
of liver transplant patients given donor bone 
marrow infusions. Significantly, we have found 
that a single systemic injection of GM-CSF-
stimulated DC progenitors can prolong organ 
(cardiac) and pancreatic islet allograft survi val. 
These ongoing and future studies should shed 
light on one of the key questions of cellular 
immunology-the balance between the 
immunogenicity and tolerogenicity of organ 
allografts. In addition, they will clarify the 
potential therapeutic role of DC lineage cells in 
organ transplantation. 
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